ARTICLE
Auteur(s) : Jaap JAJ van der Velden, Maurice AM van
Steensel
Department of Dermatology, Maastricht University Medical
Center+, P. Debijelaan 25, 6202AZ Maastricht,
the Netherlands
Pachyonychia congenita (PC) is characterized by hyperkeratosis
of the nail bed with thickening and distortion or curvature of the
nail plate [1]. There are two types of PC: Jadassohn-Lewandowsky
syndrome (PC1) and Jackson-Lawler syndrome (PC2). The PC1 phenotype
is associated with mutations in KRT6A or KRT16, whereas PC2 is
associated with mutations in KRT17 or KRT6B [1]. Although sometimes
difficult, it is possible to distinguish both subtypes clinically.
Oral leukokeratosis is seen in PC1. Steatocystomas/pilosebaceous
cysts, vellus hair cysts, hair abnormalities and natal teeth are
features of PC2. There can be considerable overlap, however [1].
Pachyonychia congenita usually begins in infancy. A late-onset
subtype seems to exist but is rare [2]. Associated skeletal
abnormalities such as acro-osteolysis [3] have been described, but
abnormal skeletal patterning has not yet been reported in the
context of PC.
Recently, a 1-year-old boy of Dutch origin was referred to our
outpatient clinic because of skeletal abnormalities of both feet
since birth and nail abnormalities that appeared later. After 42
weeks of gestation, following an uncomplicated pregnancy, he was
born with absence of one ray of both feet, an accessory phalanx at
the most lateral digit of the left foot and complete fusion of the
tibial metatarsals of the right foot (figures 1A,B). The hands
showed no skeletal defects (figure 1C). Growth and
development were normal. He was able to sweat and shed tears. At
the age of 7 months he developed thickening of the nails of both
hands and feet. His non-consanguineous Dutch parents and other
family members were not affected. Physical examination revealed
dystrophic nails with subungual hyperkeratosis and distal
onycholysis (figure
1D). A solitary, oval, tender, yellowish,
hyperkeratotic plaque was present at the plantar side of the right
foot (figure
1D). Hair and teeth appeared normal. Apart from the
oligodactyly, the accessory phalanx of the left foot, a marked
hypoplasia of the middle phalanges and the complete fusion of the
tibial metatarsalia of the right foot (figures 1E,F),
radiological examination revealed no other skeletal abnormalities.
There were no other dysmorphic traits. Based on these clinical
features the diagnosis pachyonychia congenita type I with
unclassifiable skeletal malformations was made.
Mutation analysis was performed through the International
Pachyonychia Congenita Consortium (by GeneDx, Gaithersburg, MD,
USA) and demonstrated a known heterozygous trinucleotide deletion
c.389_391delCCT (causing p.Ser130del) in exon 1 of the KRT16
gene.
The combination of pachyonychia congenita type I and the
above-mentioned unusual skeletal malformation has not been
previously described. It is tempting to speculate that the
abnormalities are not coincidental. As it seems biologically
implausible that a KRT16 mutation could affect skeletal
development, one might assume the existence of a contiguous gene
syndrome. However, that is unlikely as we found a trinucleotide
deletion in the KRT16 gene for which the patient is clearly
heterozygous, thus ruling out microdeletions encompassing all or
part of KRT16. It is therefore more prudent to assume that there is
no causal relationship. It is even debatable whether the skeletal
abnormality is genetically determined, as it cannot be classified
into one of the known categories of acral developmental
abnormalities. Thus, we think that the concurrence we describe is a
coincidental one. It is, however, quite possible that the abnormal
skeleton can contribute to the pachyonychia and concomitant
keratoderma by altering pressure distribution.
We also suggest that the other skeletal defects that have been
reported in association with pachyonychia type I were not causally
related. The relatively high frequency in the literature may be due
to an ascertainment bias.
Acknowledgements
Mutation analysis was made possible by the International
Pachyonychia Congenita Consortium. MvS is supported by the
University Hospital Maastricht, the GROW research institute for
oncology and developmental biology, the Netherlands institute for
scientific research (ZONMW) grant 907-00-202.
References
1 Leachman SA, Kaspar RL, Fleckman P, et al.
Clinical and pathological features of pachyonychia congenita. J
Investig Dermatol Symp Proc 2005; 10: 3-17.
2 Connors JB, Rahil AK, Smith FJ, McLean WH,
Milstone LM. Delayed-onset pachyonychia congenita associated
with a novel mutation in the central 2B domain of keratin 16. Br J
Dermatol 2001; 144: 1058-62.
3 Murugesh SB, Reddy S, Ragunatha S, Mohammed
Faizal MM, Shashikala P. Acro-osteolysis: a complication
of Jadassohn-Lewandowsky syndrome. Int J Dermatol 2007; 46:
202-5.
|